PDGFRA and neoplasm: The tumor growth curve (the estimated tumor size calculated from the tumor dimension versus time) with imatinib was almost the same as with vehicle (Figure 6A), which indicates in vivo resistance of BaF3-T674I PDGFRα cells to imatinib.